Annual report

Period2022-01-01 → 2022-12-31

Filed2023-03-24

StandardIFRS

ConsolidatedYes

Data checks21 of 21 passed

Key figures · 157

Metric	Value	Period	Scope	Source row
Revenue	¥2.66T	2022-01-01 → 2022-12-31	Cons.	Revenue IFRS
Revenue	¥2.32T	2021-01-01 → 2021-12-31	Cons.	Revenue IFRS
Revenue	¥2.09T	2020-01-01 → 2020-12-31^d	Cons.	Revenue IFRS (5-year summary)
Revenue	¥2.18T	2019-01-01 → 2019-12-31^d	Cons.	Revenue IFRS (5-year summary)
Revenue	¥2.22T	2018-01-01 → 2018-12-31^d	Cons.	Revenue IFRS (5-year summary)
Operating income	¥653.6bn	2022-01-01 → 2022-12-31	Cons.	Operating profit loss IFRS
Operating income	¥499.0bn	2021-01-01 → 2021-12-31	Cons.	Operating profit loss IFRS
Profit before tax	¥593.5bn	2022-01-01 → 2022-12-31	Cons.	Profit loss before tax IFRS
Profit before tax	¥472.4bn	2021-01-01 → 2021-12-31	Cons.	Profit loss before tax IFRS
Profit before tax	¥420.1bn	2020-01-01 → 2020-12-31^d	Cons.	Profit loss before tax IFRS (5-year summary)
Profit before tax	¥465.2bn	2019-01-01 → 2019-12-31^d	Cons.	Profit loss before tax IFRS (5-year summary)
Profit before tax	¥531.5bn	2018-01-01 → 2018-12-31^d	Cons.	Profit loss before tax IFRS (5-year summary)
Net income (owners)	¥442.7bn	2022-01-01 → 2022-12-31	Cons.	Profit loss attributable to owners of parent IFRS
Net income (owners)	¥338.5bn	2021-01-01 → 2021-12-31	Cons.	Profit loss attributable to owners of parent IFRS
Net income (owners)	¥310.3bn	2020-01-01 → 2020-12-31^d	Cons.	Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)	¥348.2bn	2019-01-01 → 2019-12-31^d	Cons.	Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)	¥385.7bn	2018-01-01 → 2018-12-31^d	Cons.	Profit loss attributable to owners of parent IFRS (5-year summary)
Net income	¥444.2bn	2022-01-01 → 2022-12-31	Cons.	Profit loss IFRS
Net income	¥340.2bn	2021-01-01 → 2021-12-31	Cons.	Profit loss IFRS
Net income	¥312.0bn	2020-01-01 → 2020-12-31^d	Cons.	Profit loss IFRS (5-year summary)
Net income	¥361.6bn	2019-01-01 → 2019-12-31^d	Cons.	Profit loss IFRS (5-year summary)
Net income	¥387.4bn	2018-01-01 → 2018-12-31^d	Cons.	Profit loss IFRS (5-year summary)
Total assets	¥6.55T	at 2022-12-31	Cons.	Assets IFRS
Total assets	¥5.77T	at 2021-12-31	Cons.	Assets IFRS
Total assets	¥5.38T	at 2020-12-31^d	Cons.	Total assets IFRS (5-year summary)
Total assets	¥5.55T	at 2019-12-31^d	Cons.	Total assets IFRS (5-year summary)
Total assets	¥5.46T	at 2018-12-31^d	Cons.	Total assets IFRS (5-year summary)
Total liabilities	¥2.93T	at 2022-12-31	Cons.	Liabilities IFRS
Total liabilities	¥2.89T	at 2021-12-31	Cons.	Liabilities IFRS
Net assets / equity	¥3.62T	at 2022-12-31	Cons.	Equity IFRS
Net assets / equity	¥2.89T	at 2021-12-31	Cons.	Equity IFRS
Net assets / equity	¥2.60T	at 2020-12-31^d	Cons.	Equity IFRS
Equity (owners)	¥3.54T	at 2022-12-31	Cons.	Equity attributable to owners of parent IFRS
Equity (owners)	¥2.81T	at 2021-12-31	Cons.	Equity attributable to owners of parent IFRS
Cash & equivalents	¥866.9bn	at 2022-12-31	Cons.	Cash and cash equivalents IFRS
Cash & equivalents	¥721.7bn	at 2021-12-31	Cons.	Cash and cash equivalents IFRS
Cash & equivalents	¥538.8bn	at 2020-12-31^d	Cons.	Cash and cash equivalents IFRS
Cash & equivalents	¥357.2bn	at 2019-12-31^d	Cons.	Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents	¥282.1bn	at 2018-12-31^d	Cons.	Cash and cash equivalents IFRS (5-year summary)
Operating cash flow	¥483.8bn	2022-01-01 → 2022-12-31	Cons.	Net cash provided by used in operating activities IFRS
Operating cash flow	¥598.9bn	2021-01-01 → 2021-12-31	Cons.	Net cash provided by used in operating activities IFRS
Operating cash flow	¥519.8bn	2020-01-01 → 2020-12-31^d	Cons.	Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow	¥540.4bn	2019-01-01 → 2019-12-31^d	Cons.	Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow	¥461.4bn	2018-01-01 → 2018-12-31^d	Cons.	Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow	−¥101.8bn	2022-01-01 → 2022-12-31	Cons.	Net cash provided by used in investing activities IFRS
Investing cash flow	−¥97.5bn	2021-01-01 → 2021-12-31	Cons.	Net cash provided by used in investing activities IFRS
Investing cash flow	¥5.4bn	2020-01-01 → 2020-12-31^d	Cons.	Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow	−¥123.6bn	2019-01-01 → 2019-12-31^d	Cons.	Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow	−¥383.3bn	2018-01-01 → 2018-12-31^d	Cons.	Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow	−¥306.2bn	2022-01-01 → 2022-12-31	Cons.	Net cash provided by used in financing activities IFRS
Financing cash flow	−¥353.1bn	2021-01-01 → 2021-12-31	Cons.	Net cash provided by used in financing activities IFRS
Financing cash flow	−¥297.4bn	2020-01-01 → 2020-12-31^d	Cons.	Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow	−¥333.8bn	2019-01-01 → 2019-12-31^d	Cons.	Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow	−¥62.4bn	2018-01-01 → 2018-12-31^d	Cons.	Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)	¥249.45	2022-01-01 → 2022-12-31	Cons.	Basic earnings loss per share IFRS
EPS (basic)	¥190.76	2021-01-01 → 2021-12-31	Cons.	Basic earnings loss per share IFRS
EPS (basic)	¥174.88	2020-01-01 → 2020-12-31^d	Cons.	Basic earnings loss per share IFRS (5-year summary)
EPS (basic)	¥195.97	2019-01-01 → 2019-12-31^d	Cons.	Basic earnings loss per share IFRS (5-year summary)
EPS (basic)	¥215.31	2018-01-01 → 2018-12-31^d	Cons.	Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)	¥249.36	2022-01-01 → 2022-12-31	Cons.	Diluted earnings loss per share IFRS
EPS (diluted)	¥190.68	2021-01-01 → 2021-12-31	Cons.	Diluted earnings loss per share IFRS
EPS (diluted)	¥174.8	2020-01-01 → 2020-12-31^d	Cons.	Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)	¥195.87	2019-01-01 → 2019-12-31^d	Cons.	Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)	¥215.2	2018-01-01 → 2018-12-31^d	Cons.	Diluted earnings loss per share IFRS (5-year summary)
Net assets per share	¥1,994.78	at 2022-12-31	Cons.	Equity to asset ratio IFRS (5-year summary)
Net assets per share	¥1,583.1	at 2021-12-31	Cons.	Equity to asset ratio IFRS (5-year summary)
Net assets per share	¥1,421.92	at 2020-12-31^d	Cons.	Equity to asset ratio IFRS (5-year summary)
Net assets per share	¥1,501.12	at 2019-12-31^d	Cons.	Equity to asset ratio IFRS (5-year summary)
Net assets per share	¥1,468.44	at 2018-12-31^d	Cons.	Equity to asset ratio IFRS (5-year summary)
Equity ratio	54.1%	at 2022-12-31	Cons.	Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio	48.6%	at 2021-12-31	Cons.	Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio	46.9%	at 2020-12-31^d	Cons.	Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio	47.9%	at 2019-12-31^d	Cons.	Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio	48.2%	at 2018-12-31^d	Cons.	Ratio of owners equity to gross assets IFRS (5-year summary)
ROE	13.9%	2022-01-01 → 2022-12-31	Cons.	Rate of return on equity IFRS (5-year summary)
ROE	12.7%	2021-01-01 → 2021-12-31	Cons.	Rate of return on equity IFRS (5-year summary)
ROE	12.0%	2020-01-01 → 2020-12-31^d	Cons.	Rate of return on equity IFRS (5-year summary)
ROE	13.2%	2019-01-01 → 2019-12-31^d	Cons.	Rate of return on equity IFRS (5-year summary)
ROE	14.3%	2018-01-01 → 2018-12-31^d	Cons.	Rate of return on equity IFRS (5-year summary)
Employees	52,640	at 2022-12-31	Cons.	Number of employees
Employees	55,381	at 2021-12-31	Cons.	Number of employees
Employees	58,300	at 2020-12-31^d	Cons.	Number of employees
Employees	61,975	at 2019-12-31^d	Cons.	Number of employees
Employees	63,968	at 2018-12-31^d	Cons.	Number of employees
Revenue	¥542.2bn	2022-01-01 → 2022-12-31	Standalone	Net sales
Revenue	¥592.2bn	2021-01-01 → 2021-12-31	Standalone	Net sales
Revenue	¥596.9bn	2020-01-01 → 2020-12-31^d	Standalone	Net sales (5-year summary)
Revenue	¥660.8bn	2019-01-01 → 2019-12-31^d	Standalone	Net sales (5-year summary)
Revenue	¥696.3bn	2018-01-01 → 2018-12-31^d	Standalone	Net sales (5-year summary)
Operating income	¥64.6bn	2022-01-01 → 2022-12-31	Standalone	Operating income
Operating income	¥93.8bn	2021-01-01 → 2021-12-31	Standalone	Operating income
Ordinary income	¥273.7bn	2022-01-01 → 2022-12-31	Standalone	Ordinary income
Ordinary income	¥278.8bn	2021-01-01 → 2021-12-31	Standalone	Ordinary income
Ordinary income	¥240.5bn	2020-01-01 → 2020-12-31^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥279.0bn	2019-01-01 → 2019-12-31^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥190.3bn	2018-01-01 → 2018-12-31^d	Standalone	Ordinary income loss (5-year summary)
Profit before tax	¥310.1bn	2022-01-01 → 2022-12-31	Standalone	Income before income taxes
Profit before tax	¥236.2bn	2021-01-01 → 2021-12-31	Standalone	Income before income taxes
Net income	¥283.5bn	2022-01-01 → 2022-12-31	Standalone	Profit loss
Net income	¥216.9bn	2021-01-01 → 2021-12-31	Standalone	Profit loss
Net income	¥241.8bn	2020-01-01 → 2020-12-31^d	Standalone	Net income loss (5-year summary)
Net income	¥262.5bn	2019-01-01 → 2019-12-31^d	Standalone	Net income loss (5-year summary)
Net income	¥164.6bn	2018-01-01 → 2018-12-31^d	Standalone	Net income loss (5-year summary)
Total assets	¥2.36T	at 2022-12-31	Standalone	Assets
Total assets	¥2.49T	at 2021-12-31	Standalone	Assets
Total assets	¥2.60T	at 2020-12-31^d	Standalone	Total assets (5-year summary)
Total assets	¥2.61T	at 2019-12-31^d	Standalone	Total assets (5-year summary)
Total assets	¥2.67T	at 2018-12-31^d	Standalone	Total assets (5-year summary)
Total liabilities	¥994.6bn	at 2022-12-31	Standalone	Liabilities
Total liabilities	¥1.14T	at 2021-12-31	Standalone	Liabilities
Net assets / equity	¥1.37T	at 2022-12-31	Standalone	Net assets
Net assets / equity	¥1.34T	at 2021-12-31	Standalone	Net assets
Net assets / equity	¥1.39T	at 2020-12-31^d	Standalone	Net assets
Net assets / equity	¥1.42T	at 2019-12-31^d	Standalone	Net assets (5-year summary)
Net assets / equity	¥1.49T	at 2018-12-31^d	Standalone	Net assets (5-year summary)
Cash and deposits	¥193.4bn	at 2022-12-31	Standalone	Cash and deposits
Cash and deposits	¥238.1bn	at 2021-12-31	Standalone	Cash and deposits
EPS (basic)	¥159.72	2022-01-01 → 2022-12-31	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥122.23	2021-01-01 → 2021-12-31	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥136.27	2020-01-01 → 2020-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥147.72	2019-01-01 → 2019-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥91.89	2018-01-01 → 2018-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (diluted)	¥159.66	2022-01-01 → 2022-12-31	Standalone	Diluted earnings per share (5-year summary)
EPS (diluted)	¥122.18	2021-01-01 → 2021-12-31	Standalone	Diluted earnings per share (5-year summary)
EPS (diluted)	¥136.21	2020-01-01 → 2020-12-31^d	Standalone	Diluted earnings per share (5-year summary)
EPS (diluted)	¥147.65	2019-01-01 → 2019-12-31^d	Standalone	Diluted earnings per share (5-year summary)
EPS (diluted)	¥91.84	2018-01-01 → 2018-12-31^d	Standalone	Diluted earnings per share (5-year summary)
Dividend per share	¥188	2022-01-01 → 2022-12-31	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥140	2021-01-01 → 2021-12-31	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥154	2020-01-01 → 2020-12-31^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥154	2019-01-01 → 2019-12-31^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥150	2018-01-01 → 2018-12-31^d	Standalone	Dividend paid per share (5-year summary)
Net assets per share	¥770.57	at 2022-12-31	Standalone	Net assets per share (5-year summary)
Net assets per share	¥757.1	at 2021-12-31	Standalone	Net assets per share (5-year summary)
Net assets per share	¥782.73	at 2020-12-31^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥798.18	at 2019-12-31^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥832.87	at 2018-12-31^d	Standalone	Net assets per share (5-year summary)
Equity ratio	57.9%	at 2022-12-31	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	54.0%	at 2021-12-31	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	53.5%	at 2020-12-31^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	54.2%	at 2019-12-31^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	55.9%	at 2018-12-31^d	Standalone	Equity to asset ratio (5-year summary)
ROE	20.9%	2022-01-01 → 2022-12-31	Standalone	Rate of return on equity (5-year summary)
ROE	15.9%	2021-01-01 → 2021-12-31	Standalone	Rate of return on equity (5-year summary)
ROE	17.2%	2020-01-01 → 2020-12-31^d	Standalone	Rate of return on equity (5-year summary)
ROE	18.1%	2019-01-01 → 2019-12-31^d	Standalone	Rate of return on equity (5-year summary)
ROE	10.7%	2018-01-01 → 2018-12-31^d	Standalone	Rate of return on equity (5-year summary)
Shares issued	2,000,000,000	at 2022-12-31	Standalone	Total number of issued shares (5-year summary)
Shares issued	2,000,000,000	at 2021-12-31	Standalone	Total number of issued shares (5-year summary)
Shares issued	2,000,000,000	at 2020-12-31^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	2,000,000,000	at 2019-12-31^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	2,000,000,000	at 2018-12-31^d	Standalone	Total number of issued shares (5-year summary)
Employees	5,819	at 2022-12-31	Standalone	Number of employees
Employees	7,154	at 2021-12-31	Standalone	Number of employees
Employees	7,366	at 2020-12-31^d	Standalone	Number of employees
Employees	7,464	at 2019-12-31^d	Standalone	Number of employees
Employees	7,457	at 2018-12-31^d	Standalone	Number of employees

Periods use the dates stated in the filing. ^d = earlier-year period dated by calendar; ^v = that date confirmed by the company's own earlier filing.

Segments · 86

Segment	Item	Period	Value
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	capex	2022-01-01 → 2022-12-31	¥6.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue	2022-01-01 → 2022-12-31	¥9.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue external	2022-01-01 → 2022-12-31	¥2.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue intersegment	2022-01-01 → 2022-12-31	¥7.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment profit	2022-01-01 → 2022-12-31	−¥40.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment profit	2022-01-01 → 2022-12-31	−¥40.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment profit	2022-01-01 → 2022-12-31	−¥41.1bn
Reconciling Itemsreconciling	capex	2022-01-01 → 2022-12-31	¥0
Reconciling Itemsreconciling	revenue	2022-01-01 → 2022-12-31	−¥7.9bn
Reconciling Itemsreconciling	revenue intersegment	2022-01-01 → 2022-12-31	−¥7.9bn
Reconciling Itemsreconciling	segment profit	2022-01-01 → 2022-12-31	−¥52m
Reconciling Itemsreconciling	segment profit	2022-01-01 → 2022-12-31	−¥52m
Reconciling Itemsreconciling	segment profit	2022-01-01 → 2022-12-31	−¥52m
Pharmaceuticalsreportable segment	capex	2022-01-01 → 2022-12-31	¥2.4bn
Pharmaceuticalsreportable segment	employees	at 2022-12-31	1331 pure
Pharmaceuticalsreportable segment	revenue	2022-01-01 → 2022-12-31	¥82.9bn
Pharmaceuticalsreportable segment	revenue external	2022-01-01 → 2022-12-31	¥82.9bn
Pharmaceuticalsreportable segment	segment profit	2022-01-01 → 2022-12-31	¥11.1bn
Pharmaceuticalsreportable segment	segment profit	2022-01-01 → 2022-12-31	¥11.1bn
Pharmaceuticalsreportable segment	segment profit	2022-01-01 → 2022-12-31	¥11.1bn
Processed Foodreportable segment	capex	2022-01-01 → 2022-12-31	¥8.2bn
Processed Foodreportable segment	employees	at 2022-12-31	4297 pure
Processed Foodreportable segment	revenue	2022-01-01 → 2022-12-31	¥155.5bn
Processed Foodreportable segment	revenue external	2022-01-01 → 2022-12-31	¥155.5bn
Processed Foodreportable segment	revenue intersegment	2022-01-01 → 2022-12-31	¥3m
Processed Foodreportable segment	segment profit	2022-01-01 → 2022-12-31	¥3.5bn
Processed Foodreportable segment	segment profit	2022-01-01 → 2022-12-31	¥3.5bn
Processed Foodreportable segment	segment profit	2022-01-01 → 2022-12-31	¥4.2bn
Tobaccoreportable segment	capex	2022-01-01 → 2022-12-31	¥83.8bn
Tobaccoreportable segment	employees	at 2022-12-31	46163 pure
Tobaccoreportable segment	revenue	2022-01-01 → 2022-12-31	¥2.42T
Tobaccoreportable segment	revenue external	2022-01-01 → 2022-12-31	¥2.42T
Tobaccoreportable segment	revenue intersegment	2022-01-01 → 2022-12-31	¥332m
Tobaccoreportable segment	segment profit	2022-01-01 → 2022-12-31	¥754.0bn
Tobaccoreportable segment	segment profit	2022-01-01 → 2022-12-31	¥754.0bn
Tobaccoreportable segment	segment profit	2022-01-01 → 2022-12-31	¥679.4bn
—segment total	capex	2022-01-01 → 2022-12-31	¥94.4bn
—segment total	revenue	2022-01-01 → 2022-12-31	¥2.66T
—segment total	revenue external	2022-01-01 → 2022-12-31	¥2.66T
—segment total	revenue intersegment	2022-01-01 → 2022-12-31	¥335m
—segment total	segment profit	2022-01-01 → 2022-12-31	¥768.7bn
—segment total	segment profit	2022-01-01 → 2022-12-31	¥768.7bn
—segment total	segment profit	2022-01-01 → 2022-12-31	¥694.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	capex	2021-01-01 → 2021-12-31	¥3.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue	2021-01-01 → 2021-12-31	¥7.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue external	2021-01-01 → 2021-12-31	¥2.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue intersegment	2021-01-01 → 2021-12-31	¥5.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment profit	2021-01-01 → 2021-12-31	−¥43.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment profit	2021-01-01 → 2021-12-31	−¥43.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment profit	2021-01-01 → 2021-12-31	−¥37.5bn
Reconciling Itemsreconciling	capex	2021-01-01 → 2021-12-31	−¥7m
Reconciling Itemsreconciling	revenue	2021-01-01 → 2021-12-31	−¥5.5bn
Reconciling Itemsreconciling	revenue intersegment	2021-01-01 → 2021-12-31	−¥5.5bn
Reconciling Itemsreconciling	segment profit	2021-01-01 → 2021-12-31	−¥120m
Reconciling Itemsreconciling	segment profit	2021-01-01 → 2021-12-31	−¥120m
Reconciling Itemsreconciling	segment profit	2021-01-01 → 2021-12-31	−¥120m
Pharmaceuticalsreportable segment	capex	2021-01-01 → 2021-12-31	¥6.0bn
Pharmaceuticalsreportable segment	revenue	2021-01-01 → 2021-12-31	¥80.4bn
Pharmaceuticalsreportable segment	revenue external	2021-01-01 → 2021-12-31	¥80.4bn
Pharmaceuticalsreportable segment	segment profit	2021-01-01 → 2021-12-31	¥11.1bn
Pharmaceuticalsreportable segment	segment profit	2021-01-01 → 2021-12-31	¥11.1bn
Pharmaceuticalsreportable segment	segment profit	2021-01-01 → 2021-12-31	¥11.3bn
Processed Foodreportable segment	capex	2021-01-01 → 2021-12-31	¥10.7bn
Processed Foodreportable segment	revenue	2021-01-01 → 2021-12-31	¥147.2bn
Processed Foodreportable segment	revenue external	2021-01-01 → 2021-12-31	¥147.2bn
Processed Foodreportable segment	revenue intersegment	2021-01-01 → 2021-12-31	¥1m
Processed Foodreportable segment	segment profit	2021-01-01 → 2021-12-31	¥4.0bn
Processed Foodreportable segment	segment profit	2021-01-01 → 2021-12-31	¥4.0bn
Processed Foodreportable segment	segment profit	2021-01-01 → 2021-12-31	¥2.9bn
Tobaccoreportable segment	capex	2021-01-01 → 2021-12-31	¥81.0bn
Tobaccoreportable segment	revenue	2021-01-01 → 2021-12-31	¥2.10T
Tobaccoreportable segment	revenue external	2021-01-01 → 2021-12-31	¥2.10T
Tobaccoreportable segment	revenue intersegment	2021-01-01 → 2021-12-31	¥411m
Tobaccoreportable segment	segment profit	2021-01-01 → 2021-12-31	¥639.2bn
Tobaccoreportable segment	segment profit	2021-01-01 → 2021-12-31	¥639.2bn
Tobaccoreportable segment	segment profit	2021-01-01 → 2021-12-31	¥522.4bn
—segment total	capex	2021-01-01 → 2021-12-31	¥97.7bn
—segment total	revenue	2021-01-01 → 2021-12-31	¥2.32T
—segment total	revenue external	2021-01-01 → 2021-12-31	¥2.32T
—segment total	revenue intersegment	2021-01-01 → 2021-12-31	¥412m
—segment total	segment profit	2021-01-01 → 2021-12-31	¥654.3bn
—segment total	segment profit	2021-01-01 → 2021-12-31	¥654.3bn
—segment total	segment profit	2021-01-01 → 2021-12-31	¥536.7bn
Pharmaceuticalsreportable segment	employees	at 2022-12-31	732 pure
Processed Foodreportable segment	employees	at 2022-12-31	23 pure
Tobaccoreportable segment	employees	at 2022-12-31	4667 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 2,113

Item	Context	Value	Unit
Promotion expenses sga	CurrentYearDuration_NonConsolidatedMember	30422000000	JPY
Compensations salaries and allowances sga	Prior1YearDuration_NonConsolidatedMember	30205000000	JPY
Compensations salaries and allowances sga	CurrentYearDuration_NonConsolidatedMember	26552000000	JPY
Provision for bonuses sga	Prior1YearDuration_NonConsolidatedMember	4019000000	JPY
Provision for bonuses sga	CurrentYearDuration_NonConsolidatedMember	3976000000	JPY
Retirement benefit expenses sga	Prior1YearDuration_NonConsolidatedMember	7852000000	JPY
Retirement benefit expenses sga	CurrentYearDuration_NonConsolidatedMember	6379000000	JPY
Commission fee sga	Prior1YearDuration_NonConsolidatedMember	43522000000	JPY
Commission fee sga	CurrentYearDuration_NonConsolidatedMember	46557000000	JPY
Depreciation sga	Prior1YearDuration_NonConsolidatedMember	63170000000	JPY
Depreciation sga	CurrentYearDuration_NonConsolidatedMember	61687000000	JPY
Research and development expenses sga	Prior1YearDuration_NonConsolidatedMember	53902000000	JPY
Research and development expenses sga	CurrentYearDuration_NonConsolidatedMember	53528000000	JPY
Document title cover page	FilingDateInstant	Original text (Japanese) 有価証券報告書
Clause of stipulation cover page	FilingDateInstant	Original text (Japanese) 金融商品取引法第24条第１項
Place of filing cover page	FilingDateInstant	Original text (Japanese) 関東財務局長
Filing date cover page	FilingDateInstant	2023-03-24
Fiscal year cover page	FilingDateInstant	Original text (Japanese) 第38期（自　2022年１月１日　至　2022年12月31日）
Company name cover page	FilingDateInstant	Original text (Japanese) 日本たばこ産業株式会社
Company name in english cover page	FilingDateInstant	JAPAN TOBACCO INC.
Title and name of representative cover page	FilingDateInstant	Original text (Japanese) 代表取締役社長　　寺畠　正道
Address of registered headquarter cover page	FilingDateInstant	Original text (Japanese) 東京都港区虎ノ門四丁目１番１号
Telephone number address of registered headquarter cover page	FilingDateInstant	Original text (Japanese) ０３（６６３６）２９１４（代表）
Name of contact person address of registered headquarter cover page	FilingDateInstant	Text · Plus
Nearest place of contact cover page	FilingDateInstant	Original text (Japanese) 東京都港区虎ノ門四丁目１番１号
Telephone number nearest place of contact cover page	FilingDateInstant	Original text (Japanese) ０３（６６３６）２９１４（代表）
Name of contact person nearest place of contact cover page	FilingDateInstant	Text · Plus
Place for public inspection cover page (text)	FilingDateInstant	Text · Plus
Edinet code	FilingDateInstant	E00492
Fund code	FilingDateInstant	－
Security code	FilingDateInstant	29140
Filer name in japanese	FilingDateInstant	Original text (Japanese) 日本たばこ産業株式会社
Filer name in english	FilingDateInstant	JAPAN TOBACCO INC.
Fund name in japanese	FilingDateInstant	－
Fund name in english	FilingDateInstant	－
Cabinet office ordinance	FilingDateInstant	Original text (Japanese) 企業内容等の開示に関する内閣府令
Document type	FilingDateInstant	Original text (Japanese) 第三号様式
Accounting standards	FilingDateInstant	IFRS
Whether consolidated financial statements are prepared	FilingDateInstant	true
Industry code when consolidated financial statements are prepared in accordance with industry specific regulations	FilingDateInstant	CTE
Industry code when financial statements are prepared in accordance with industry specific regulations	FilingDateInstant	CTE
Current fiscal year start date	FilingDateInstant	2022-01-01
Current period end date	FilingDateInstant	2022-12-31
Type of current period	FilingDateInstant	FY
Current fiscal year end date	FilingDateInstant	2022-12-31
Previous fiscal year start date	FilingDateInstant	2021-01-01
Comparative period end date	FilingDateInstant	2021-12-31
Previous fiscal year end date	FilingDateInstant	2021-12-31
Next fiscal year start date	FilingDateInstant	－
End date of quarterly or semi annual period of next fiscal year	FilingDateInstant	－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed

balance sheet identity	consolidated 2021-12-31	pass
balance sheet identity	consolidated 2022-12-31	pass
balance sheet identity	non_consolidated 2021-12-31	pass
balance sheet identity	non_consolidated 2022-12-31	pass rounding
dei present		pass
period resolution		pass
statement vs summary · net assets	non_consolidated 2020-12-31	pass
statement vs summary · net assets	non_consolidated 2021-12-31	pass
statement vs summary · net assets	non_consolidated 2022-12-31	pass
statement vs summary · net income attributable to parent	consolidated 2021-01-01/2021-12-31	pass
statement vs summary · net income attributable to parent	consolidated 2022-01-01/2022-12-31	pass
statement vs summary · operating cash flow	consolidated 2021-01-01/2021-12-31	pass
statement vs summary · operating cash flow	consolidated 2022-01-01/2022-12-31	pass
statement vs summary · revenue	consolidated 2021-01-01/2021-12-31	pass
statement vs summary · revenue	consolidated 2022-01-01/2022-12-31	pass
statement vs summary · revenue	non_consolidated 2021-01-01/2021-12-31	pass
statement vs summary · revenue	non_consolidated 2022-01-01/2022-12-31	pass
statement vs summary · total assets	consolidated 2021-12-31	pass
statement vs summary · total assets	consolidated 2022-12-31	pass
statement vs summary · total assets	non_consolidated 2021-12-31	pass
statement vs summary · total assets	non_consolidated 2022-12-31	pass